Business Wire

IMS Health Reports Annual Global Generics Prescription Sales Growth of 3.6 Percent, to $78 Billion

NORWALK, Conn.--(BUSINESS WIRE)--Global prescription sales growth of generics drugs slowed to 3.6 percent in the twelve months ending September 2008, down from 11.4 percent in 2007, according to a new ...
Seeking Alpha

IMS Health Q4 2005 Earnings Conference Call Transcript (RX)

IMS Health (RX) Q4 2005 Earnings Conference Call January 31st 2006, 8:30 AM.ExecutivesDarcie Peck, Vice President, Investor Relations David Carlucci, ...
Business Wire

IMS Health Reports U.S. Prescription Sales Grew 3.8 Percent in 2007, to $286.5 Billion

NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today released its annual U.S.
MM&M

Prescription drug sales up 5.4% in 2005: IMS Health

US prescription drug sales grew 5.4% to $251.8 billion in 2005, compared with $238.9 billion in sales the previous year, according to healthcare information firm IMS Health. The sales figures are ...
Drug Store News

IMS Health projects growth for Rx market

NORWALK, Conn. The global pharmaceutical market will reach a value of $880 billion next year, according to a report by market research firm IMS Health. IMS Health forecasted 5% to 7% growth in 2011 in ...
FiercePharma

IMS Health Reports U.S. Prescription Sales Grew 5.1 Percent in 2009, to $300.3 Billion

IMS Health Reports U.S. Prescription Sales Grew 5.1 Percent in 2009, to $300.3 Billion NORWALK, Conn.--(BUSINESS WIRE)--IMS Health today reported 5.1 percent growth in 2009 U.S. sales of ethical ...